1. Home
  2. SLMBP vs GKOS Comparison

SLMBP vs GKOS Comparison

Compare SLMBP & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLMBP
  • GKOS
  • Stock Information
  • Founded
  • SLMBP N/A
  • GKOS 1998
  • Country
  • SLMBP United States
  • GKOS United States
  • Employees
  • SLMBP 1710
  • GKOS N/A
  • Industry
  • SLMBP Finance: Consumer Services
  • GKOS Medical/Dental Instruments
  • Sector
  • SLMBP Finance
  • GKOS Health Care
  • Exchange
  • SLMBP Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • SLMBP N/A
  • GKOS 5.1B
  • IPO Year
  • SLMBP N/A
  • GKOS 2015
  • Fundamental
  • Price
  • SLMBP $70.45
  • GKOS $89.58
  • Analyst Decision
  • SLMBP
  • GKOS Strong Buy
  • Analyst Count
  • SLMBP 0
  • GKOS 13
  • Target Price
  • SLMBP N/A
  • GKOS $155.00
  • AVG Volume (30 Days)
  • SLMBP N/A
  • GKOS 987.1K
  • Earning Date
  • SLMBP N/A
  • GKOS 04-30-2025
  • Dividend Yield
  • SLMBP N/A
  • GKOS N/A
  • EPS Growth
  • SLMBP N/A
  • GKOS N/A
  • EPS
  • SLMBP N/A
  • GKOS N/A
  • Revenue
  • SLMBP N/A
  • GKOS $383,481,000.00
  • Revenue This Year
  • SLMBP N/A
  • GKOS $27.84
  • Revenue Next Year
  • SLMBP N/A
  • GKOS $27.99
  • P/E Ratio
  • SLMBP N/A
  • GKOS N/A
  • Revenue Growth
  • SLMBP N/A
  • GKOS 21.85
  • 52 Week Low
  • SLMBP N/A
  • GKOS $77.91
  • 52 Week High
  • SLMBP N/A
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • SLMBP 41.31
  • GKOS 42.68
  • Support Level
  • SLMBP $69.29
  • GKOS $87.17
  • Resistance Level
  • SLMBP $71.35
  • GKOS $94.55
  • Average True Range (ATR)
  • SLMBP 1.46
  • GKOS 6.20
  • MACD
  • SLMBP -0.07
  • GKOS 1.09
  • Stochastic Oscillator
  • SLMBP 55.37
  • GKOS 55.58

About SLMBP SLM Corporation Floating Rate Non-Cumulative Preferred Stock Series B

SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: